Cuu Long Pharmaceutical Joint Stock Company provided earnings guidance for the fiscal year 2022. For the period, the company expects net revenue to be VND 845,510 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
27,300 VND | 0.00% | +5.41% | +9.20% |
1st Jan change | Capi. | |
---|---|---|
+9.20% | 78.9M | |
+26.47% | 664B | |
+24.92% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.87% | 234B | |
+4.47% | 199B | |
-9.90% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- DCL Stock
- News Cuu Long Pharmaceutical
- Cuu Long Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2022